Zhejiang Zhenyuan Co., Ltd. operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Zhenyuan Co., Ltd. with three other
companies in this sector in China:
China Resources Medical Holdings Co Ltd
sales of 2.06 billion Chinese Renmimbi [US$307.93 million]
Jiangsu Nhwa Pharmaceutical Company Limited
(3.86 billion Chinese Renmimbi [US$576.87 million]
of which 63%
was Medical Industrial Manufacturing), and
China Pioneer Pharma Holdings Ltd
(1.62 billion Chinese Renmimbi [US$242.87 million]
of which 56%
was Products sold via the provision of compr).
Zhejiang Zhenyuan Co., Ltd. reported sales of 2.86 billion Chinese Renmimbi (US$427.34 million)
December of 2018.
increase of 10.9%
versus 2017, when the company's sales were 2.58 billion Chinese Renmimbi.
Sales at Zhejiang Zhenyuan Co., Ltd. have increased during each of the previous five years
(and since 2013, sales have increased a total of 42%).
Sales of Medicines Manufacturing saw an increase
that was more than double the company's growth rate: sales were up
46.2% in 2018, from
448.15 million Chinese Renmimbi to 655.31 million Chinese Renmimbi.
Not all segments of Zhejiang Zhenyuan Co., Ltd. experienced an increase in sales in 2018:
sales of Other Business fell 14.4% to 11.90 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).